Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT01420172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-02-27

No results posted yet for this study

Summary

This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.

This study will determine factors influencing pulmonary disease and associated treatment strategies.

Conditions

  • Post Hematopoietic Stem Cell Transplantation

Interventions

OTHER

Data Collection

Collection of data on patients who were seen at OSUMC at any time between 01Jan2000 and 30Jun2011 post hematopoietic stem cell transplantation

Sponsors & Collaborators

  • Karen Wood

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2016-07-08
Completion
2016-07-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01420172 on ClinicalTrials.gov